Grifols SA logo

Grifols SA - PRF PERPETUAL EUR 0.

XMAD:GRF.P (Spain)   PRF PERPETUAL EUR 0.05 - Cls B
€ 5.71 (-3.38%) Apr 25
31.37
P/B:
0.95
Market Cap:
€ 4.88B ($ 5.23B)
Enterprise V:
€ 14.35B ($ 15.38B)
Volume:
217.60K
Avg Vol (2M):
442.68K
Also Trade In:

Business Description

Description
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.